Townsquare Capital LLC Has $7.82 Million Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• Townsquare Capital LLC increased its position in Prestige Consumer Healthcare by 5.0%, now holding 91,002 shares valued at approximately $7.82 million.
• Prestige Consumer Healthcare's stock is down 3.0%, with the company reporting earnings of $0.95 per share, missing estimates by $0.06, and experiencing a 6.6% decline in revenue year-over-year.
• Analyst ratings on Prestige Consumer Healthcare vary, with four firms rating it as a "hold" while three provide a "buy" rating, indicating mixed sentiment among investors.

Townsquare Capital LLC boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 5.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,002 shares of the company's stock after buying an additional 4,318 shares during the period. Townsquare Capital LLC owned approximately 0.18% of Prestige Consumer Healthcare worth $7,823,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the business. Cerity Partners LLC lifted its holdings in Prestige Consumer Healthcare by 3.7% in the first quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock valued at $315,000 after buying an additional 132 shares during the period. Franklin Resources Inc. lifted its holdings in Prestige Consumer Healthcare by 0.7% in the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after buying an additional 150 shares during the period. KBC Group NV lifted its holdings in Prestige Consumer Healthcare by 7.4% in the first quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after buying an additional 151 shares during the period. McIlrath & Eck LLC lifted its holdings in Prestige Consumer Healthcare by 19.1% in the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after buying an additional 154 shares during the period. Finally, Xponance Inc. increased its stake in Prestige Consumer Healthcare by 5.5% in the first quarter. Xponance Inc. now owns 3,766 shares of the company's stock valued at $324,000 after purchasing an additional 196 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 3.0%

Shares of PBH stock opened at $65.61 on Friday. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of 15.40, a P/E/G ratio of 2.03 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 12-month low of $63.78 and a 12-month high of $90.04. The firm has a fifty day moving average of $79.26 and a 200-day moving average of $82.02. The company has a quick ratio of 2.82, a current ratio of 4.38 and a debt-to-equity ratio of 0.55.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm's revenue for the quarter was down 6.6% on a year-over-year basis. During the same period last year, the business posted $0.90 EPS. As a group, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Finally, Canaccord Genuity Group lowered their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a research note on Friday. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.